Phenotypic modulation of SMCs during human atherosclerosis is characterized by the downregulation of contractile SMC marker genes such as MYH11, TAGLN and CNN1, and activation of gene programs that promote vascular remodeling, lesion development and fibrous cap formation. The gene discussed is TAGLN; the disease is atherosclerosis.